Challenging the Status Quo: Cancer Research, COVID-19, and Emerging Therapies with Dr. William Makis

In this episode of Integrative Medicine with Dr. Leland Stillman, we welcome Dr. William Makis, a physician specializing in radiology and oncology, to discuss his career in cancer research and his perspectives on medical innovation. Dr. Makis shares his background in nuclear medicine and targeted radionuclide therapy, as well as the challenges he faced in advancing new treatment protocols. He also highlights the impact of regulatory policies on patient access to emerging therapies and the role of government and industry in shaping cancer treatment options.

We explore the evolving landscape of cancer care, including recent discussions surrounding post-pandemic health concerns and the phenomenon some have referred to as "turbo cancer." Dr. Makis discusses the potential role of repurposed medications, ongoing research into alternative approaches, and the importance of an individualized treatment strategy for patients navigating complex diagnoses. He also touches on broader issues of informed consent and the need for open scientific dialogue in medical decision-making.

Finally, we discuss patient advocacy, the integration of conventional and emerging therapies, and strategies for those seeking additional options in their care journey. Dr. Makis shares his insights on the importance of patient education, collaboration between healthcare providers, and the future of oncology research. This episode provides valuable information for anyone interested in a comprehensive approach to cancer care and the ongoing pursuit of medical innovation.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit stillmanmd.substack.com/subscribe